Pfizer Inc (PFE BE) stock market data APIs
€20.6087
-0.32(-1.6%)
as of September 18, 2025
Try our APIs with
free plan!
Pfizer Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for PFE.BE.
Prev. Close
20.6087
Open
20.2906
High
20.6087
Low
20.2906
52 wk Range
18.5147-25.8846
Market Cap
262 316 M
Dividends (Yield)
0.0336
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pfizer Inc data using free add-ons & libraries
Get Pfizer Inc Fundamental Data
Pfizer Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pfizer Inc News
New
Can CorMedix's Melinta Deal Fuel Growth Via Portfolio Diversification?
CorMedix CRMD has taken a major step toward diversifying its revenue base and reducing reliance on a single product with the recent $300 million acquisition of Melinta Therapeutics. The move significa...
Atlassian to acquire developer productivity platform DX for $1 billion
(Reuters) - Atlassian said on Thursday it has agreed to acquire developer intelligence platform DX for about $1 billion in cash and restricted stock, aiming to improve customer experience by providing...
Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer
COPENHAGEN, Denmark, September 18, 2025--(BUSINESS WIRE)--Neumirna Therapeutics, a biotechnology company developing RNA-based therapies for neurological diseases, today announced the appointment of El...
1 Large-Cap Stock Worth Your Attention and 2 We Find Risky
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rat...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
